The 340B program has evolved into a “buy low, sell high” drug pricing system abused by some hospitals that have profits as their main goal, a health policy researcher told lawmakers Wednesday at a U.S. House subcommittee hearing.
The House
…
Category: Legislative
Louisiana Takes Major Step Towards Prohibiting Drug Manufacturer 340B Contract Pharmacy Restrictions
The Louisiana House voted 97-2 yesterday to pass and send to the Senate legislation to stop drug manufacturer interference with 340B contract pharmacy arrangements. It also would prohibit pharmacy benefit manager and payor practices that lower reimbursement for 340B-purchased drugs.
…
The Iowa Senate last week passed a House-approved bill banning pharmacy benefit manager and payor discrimination against 340B covered entities and their contract pharmacies, including reimbursing the entities at a lower rate than non-340B providers.
The Senate voted 49-1 on
…
U.S. Rep. Larry Bucshon (R-Ind.), vice chair of the House Energy & Commerce health subcommittee, has written a bill to impose significant 340B program reporting requirements on disproportionate share hospitals and potentially other covered entities. Meanwhile, two bills have been
…
U.S. Health Resources and Services Administration Administrator Carole Johnson said on Capitol Hill yesterday that HRSA would welcome congressional help ensuring there is “accountability and transparency” in the 340B program.
Johnson was answering questions from Rep. Morgan Griffith (R-Va.) during
…
With just weeks to go in its legislative session, Missouri lawmakers are making progress on two different 340B anti-discrimination bills. Last week, a key Senate committee approved SB 26, comprehensive legislation with two key priorities: prohibiting drug manufacturers from placing
…
A California Senate health committee yesterday unanimously approved a bill to prohibit pharmacy benefit managers from employing practices that 340B covered entities view as discriminatory. On Wednesday, California’s SB-786 was approved by the Senate Health Committee and now goes
…
About a dozen people who advise, help run, or work at 340B covered entities are launching a nonprofit group, 340B Truth, to try to hammer out a covered entity consensus position on 340B reform and urge Congress to pass it
…
A hearing is set for Thursday in the Louisiana House on a bill to stop drug manufacturers from impeding 340B covered entities’ use of contract pharmacies.
State Rep. Chris Turner (R) introduced House Bill 548, the Defending Affordable Prescription
…